Dr. Pelura joined Immunome in September of 2009 as President and CEO. He is a serial life science entrepreneur with over 35 years of experience in the pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas. He has several successful financings and exits to his credit.
Dr. Pelura holds a Ph.D. in chemistry from Rutgers University.

Dr. Dessain is an Associate Professor at the Lankenau Institute for Medical Research, Wynnewood PA. He received M.D. and Ph.D. degrees from Yale University in 1994. He pursued post-graduate medical training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Medical Oncology at Dana Farber/Partners Cancer Care Boston, MA. His post-doctoral training was with Dr. Robert Weinberg at the Whitehead Institute in Cambridge,

Mr. Hobbs has more than 20 years of experience in the life science industry. Before joining Immunome in 2009, George had a leadership role in the formation and management of a start-up company that advanced a novel cellular therapy from discovery to clinical testing. He was also a member of the senior management team for 13 years at Centocor, Inc. during the successful development of several products; and a $4.9 billion merger with J&J.